Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research

PETQuant: Neurodegenerative Assessment in Clinical Research

webinar_thumbnail.pngDr. James Brewer, MD, PhD, Neurologist, UC San Diego, hosted a live webinar from our our San Diego headquarters entitled: PETQuant™: Neurodegenerative Dementia Assessment in Research. Dr. Brewer gave a fascinating and enlightening presentation about using PETQuant in clinical research and covered many topics in the video below, including:

  • Why patient native brain space is important in PET imaging
  • The value of quantifying brain structure volumes (via NeuroQuant®)
  • How PETQuant can simplify the process of interpreting PET scans
  • Several case studies

PETQuant is our recently launched for research only tool that provides brain segmentation using PET imaging studies to quantify subregional tracer binding in native brain space for FDG and Florbetapir.

If you would like more information about using PETQuant in your clinical research, please contact us.

More Resources

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions

10/07/2025

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions.

10/06/2025

Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis

NeuroQuant has consistently demonstrated strong clinical performance across multiple conditions, including Alzheimer’s , epilepsy, TBI, and MS.

10/02/2025

WEBINAR: Navigating Category III CPT Codes for Quantitative Imaging

Leveraging Compatible CPT Codes for NeuroQuant and OnQ Prostate

09/29/2025

The Role of NeuroQuant in Supporting Alzheimer’s Disease Care

NeuroQuant equips clinicians and researchers with data that can support earlier recognition of disease, track progression, and evaluate treatment efficacy.
Scroll to Top